[Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]
Journal
Kardiologiia
ISSN: 0022-9040
Titre abrégé: Kardiologiia
Pays: Russia (Federation)
ID NLM: 0376351
Informations de publication
Date de publication:
16 Sep 2020
16 Sep 2020
Historique:
received:
21
07
2020
accepted:
29
07
2020
entrez:
24
11
2020
pubmed:
25
11
2020
medline:
26
11
2020
Statut:
epublish
Résumé
Recommendation provides information to employees of medical departments at any level and primarily primary care about the possible proarrhythmic and adverse effects of drugs used for the treatment of COVID-19 patients and the features of therapy for COVID-19 patients with heart rhythm and conduction disorders receiving permanent antiarrhythmic therapy.
Identifiants
pubmed: 33228499
doi: 10.18087/cardio.2020.10.n1283
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Langues
rus
Sous-ensembles de citation
IM